Medina MR; González GI, Maldonado LCJ, Calzada RAN

Language: Spanish
References: 23
Page: 132-137
PDF size: 300.66 Kb.

ABSTRACT

Candida tropicalis is an asexual dimorphic yeast, non-albicans species most frequently associated with candidemia and invasive candidiasis, with chronic disseminated candidiasis being an invasive form, characterized by hepato-splenic involvement.
Clinical case. 56-year-old woman diagnosed with acute myeloid leukemia treated with second-line chemotherapy, admitted for salvage chemotherapy, presenting neutropenia and fever on day + 11, broad-spectrum antibiotics were started, persisting with fever, adding painful syndrome abdominal, abdominal tomography was performed with the presence of hepatosplenic fungomas, amphotericin b deoxycholate was started empirically, isolation of pan-sensitive C. tropicalis in blood cultures, adjustment to echinocandins with clinical improvement after 72 hours. In only 5% of cases of invasive candidemias are they proven, so clinical suspicion is essential for the early initiation of antifungal treatment, with the aim of reducing the risk of lethal outcomes.

REFERENCES

1. Giri, S. y Kindo, A.J., “A review of Candida species causingblood stream infection”, Indian J Med Microbiol, 2012, 30 (3): 270-278.

2. Zheng, Y.J., Xie, T., Wu, L., Liu, X.Y., Zhu, L., Chen, Y.,Mao, E.Q., Han, L.Z., Chen, E.Z. y Yang, Z.T., “Epidemiology,species distribution, and outcome of nosocomial Candidaspp. bloodstream infection in Shanghai: an 11-yearretrospective analysis in a tertiary care hospital”, Ann ClinMicrobiol Antimicrob, 2021, 20 (1): 34.

3. Pappas, P.G., Lionakis, M.S., Arendrup, M.C., Ostrosky-Zeichner, L. y Kullberg, B.J., “Invasive candidiasis”, NatRev Dis Primers, 2018, 4: 18026.

4. Barantsevich, N. y Barantsevich, E., “Diagnosis and treatmentof invasive candidiasis”, Antibiotics (Basilea), 2022,11 (6): 718.

5. Liu, F., Zhong, L., Zhou, F., Zheng, C., Zhang, K., Cai, J.,Zhou, H., Tang, K., Dong, Z., Cui, W. y Zhang, G., “Clinicalfeatures, strain distribution, antifungal resistance andprognosis of patients with non-albicans candidemia: aretrospective observational study”, Infect Drug Resist,2021, 14: 3233-3246.

6. McCarty, T.P., White, C.M. y Pappas, P.G., “Candidemiaand invasive candidiasis”, Infect Dis Clin North Am, 2021,35 (2): 389-413.

7. Bassetti, M., Azoulay, E., Kullberg, B.J., Ruhnke, M., Shoham,S., Vázquez, J., Giacobbe, D.R. y Calandra, T., “eortc/msgerc definitions of invasive fungal diseases: summaryof activities of the Intensive Care Unit Working Group”,Clin Infect Dis, 2021, 72 (Suppl 2): S121-S127.

8. Riera, F.O., Caeiro, J.P., Angiolini, S.C., Vigezzi, C., Rodríguez,E., Icely, P.A. y Sotomayor, C.E., “Invasive candidiasis:update and current challenges in the management ofthis mycosis in South America”, Antibiotics (Basilea), 2022,11 (7): 877.

9. Pagano, L., Mele, L., Fianchi, L., Melillo, L., Martino, B.,D’Antonio, D. et al., “Chronic disseminated candidiasis inpatients with hematologic malignancies. Clinical featuresand outcome of 29 episodes”, Haematologica, 2002, 87:535-541.

10. D’Enfert, C., Kaune, A.K., Alaban, L.R., Chakraborty, S., Cole,N., Delavy, M. et al., “The impact of the fungus-host-microbiotainterplay upon Candida albicans infections:current knowledge and new perspectives”, fems MicrobiolRev, 2021, 45 (3): fuaa060.

11. Van de Veerdonk, F.L., Kullberg, B.J. y Netea, M.G., “Pathogenesisof invasive candidiasis”, Curr Opin Crit Care,2010, 16 (5): 453-459.

12. Sallah, S., Wan, J.Y., Nguyen, N.P., Vos, P. y Sigounas, G.,“Analysis of factors related to the occurrence of chronicdisseminated candidiasis in patients with acute leukemiain a non-bone marrow transplant setting: a follow-upstudy”, Cancer, 2001, 92 (6): 1349-1353.

13. Masood, A. y Sallah, S., “Chronic disseminated candidiasisin patients with acute leukemia: emphasis on diagnosticdefinition and treatment”, Leuk Res, 2005, 29 (5): 493-501.

14. Sallah, S., Semelka, R.C., Wehbie, R., Sallah, W., Nguyen,N.P. y Vos, P., “Hepatosplenic candidiasis in patients withacute leukaemia”, Br J Haematol, 2019, 106 (3): 697-701.

15. Rossetti, F., Brawner, D.L., Bowden, R., Meyer, W.G.,Schoch, H.G., Fisher, L., Myerson, D., Hackman, R.C.,Shulman, H.M., Sale, G.E. et al., “Fungal liver infectionin marrow transplant recipients: prevalence at autopsy,predisposing factors, and clinical features”, Clin InfectDis, 1995, 20 (4): 801-811.

16. Semelka, R.C., Shoenut, J.P., Greenberg, H.M. y Bow, E.J.,“Detection of acute and treated lesions of hepatospleniccandidiasis: comparison of dynamic contrast-enhancedct and mr imaging”, J Magn Reson Imaging, 1992, 2 (3):341-345.

17. Walsh, T.J., Merz, W.G., Lee, J.W., Schaufele, R., Sein, T.,Whitcomb, P.O., Ruddel, M., Burns, W., Wingard, J.R., Switchenko,A.C. et al., “Diagnosis and therapeutic monitoringof invasive candidiasis by rapid enzymatic detection ofserum d-arabinitol”, Am J Med, 1995, 99 (2): 164-172.

18. Mroczyńska, M. y Brillowska-Dąbrowska, A., “Review oncurrent status of echinocandins use”, Antibiotics (Basilea),2020, 9 (5): 227.

19. Andes, D.R., Safdar, N., Baddley, J.W., Playford, G., Reboli,A.C., Rex, J.H., Sobel, J.D., Pappas, P.G. y Kullberg, B.J.,“Mycoses Study Group. Impact of treatment strategy onoutcomes in patients with candidemia and other forms ofinvasive candidiasis: a patient-level quantitative review ofrandomized trials”, Clin Infect Dis, 2012, 54 (8): 1110-1122.

20. Taur, Y., Cohen, N., Dubnow, S., Paskovaty, A. y Seo, S.K.,“Effect of antifungal therapy timing on mortality in cancerpatients with candidemia”, Antimicrob Agents Chemother,2010, 54 (1): 184-190.

21. Peter, G., Pappas, P.G. et al., “Clinical practice guidelinefor the management of candidiasis: 2016 update by theInfectious Diseases Society of America”, Clin Infect Dis,2016, 62 (4): e1-e50.

22. Legrand, F., Lecuit, M., Dupont, B., Bellaton, E., Huerre,M., Rohrlich, P.S. y Lortholary, O., “Adjuvant corticosteroidtherapy for chronic disseminated candidiasis”, Clin InfectDis, 2008, 46 (5): 696-702.

23. Chaussade, H., Bastides, F., Lissandre, S., Blouin, P., Bailly,E., Chandenier, J., Gyan, E. y Bernard, L., “Usefulness ofcorticosteroid therapy during chronic disseminated candidiasis:case reports and literature review”, J AntimicrobChemother, 2012, 67 (6): 1493-1495.